Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0000947871-23-000438

10% owner sold 102,630 shares at an average $2.16 ($221,994)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ORBIMED ADVISORS LLC 10% owner 2023-04-05 Sale −4,687 $2.18 $10,218 187,100 I: show line 1 in the form
ORBIMED ADVISORS LLC 10% owner 2023-04-05 Sale −25,220 $2.18 $54,980 1,006,591 I: show line 2 in the form
ORBIMED ADVISORS LLC 10% owner 2023-04-05 Sale −63,058 $2.18 $137,466 2,516,599 I: show line 3 in the form
ORBIMED ADVISORS LLC 10% owner 2023-04-06 Sale −487 $2.00 $974 186,613 I: show line 4 in the form
ORBIMED ADVISORS LLC 10% owner 2023-04-06 Sale −2,620 $2.00 $5,240 1,003,971 I: show line 5 in the form
ORBIMED ADVISORS LLC 10% owner 2023-04-06 Sale −6,558 $2.00 $13,116 2,510,041 I: show line 6 in the form
Open-market sales · 102,630 sh · avg $2.16 · $221,994
Loading xslF345X04/ownership.xml…